Vitamin B6 suppresses apoptosis of NM-1 bovine endothelial cells induced by homocysteine and copper

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 4, 2007, Pages 571-577

  Endo, Naoko ^a   Nishiyama, Kazuo ^b   Okabe, Masaaki ^a   Matsumoto, Mitsuharu ^a   Kanouchi, Hiroaki ^a   Oka, Tatsuzo ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Antioxidant; Apoptosis; Copper; Homocysteine; NM 1 cells; Vitamin B6

Indexed keywords

CASPASE; CASPASE INHIBITOR; COPPER; CYTOCHROME C; DNA FRAGMENT; EDETIC ACID; HOMOCYSTEINE; HYDROGEN PEROXIDE; LIPID PEROXIDE; PYRIDOXINE; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT; CATALASE; COPPER SULFATE; PYRIDOXAL; PYRIDOXAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; COW; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; MITOCHONDRIAL PERMEABILITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; ANIMAL; CATTLE; CELL LINE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; LIPID PEROXIDATION; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

BOVINAE; RATTUS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CATALASE; CATTLE; CELL LINE; CELL SURVIVAL; COPPER SULFATE; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; HOMOCYSTEINE; HYDROGEN PEROXIDE; IN SITU NICK-END LABELING; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; PYRIDOXAL; PYRIDOXAMINE; PYRIDOXINE; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN B 6;

EID: 33847100940     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2006.11.009     Document Type: Article

References (25)

1. Eikelboom J.W., Lonn E., Genest Jr. J., Hankey G., and Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann. Intern. Med. 131 (1999) 363-375
2. Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin. Chem. Lab. Med. 39 (2001) 666-674
3. Durand P., Prost M., Loreau N., Lussier-Cacan S., and Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab. Invest. 81 (2001) 645-672
4. Topal G., Brunet A., Millanvoye E., Boucher J., Rendu F., Devynck M., and David-Dufilho M. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic. Biol. Med. 36 (2004) 1532-1541
5. Lynch S.M., and Frei B. Physiological thiol compounds exert pro- and anti-oxidant effects, respectively, on iron- and copper-dependent oxidation of human low-density lipoprotein. Biochim. Biophys. Acta 1345 (1997) 215-221
6. Poddar R., Sivasubramanian N., DiBello P.M., Robinson K., and Jacobsen D.W. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103 (2001) 2717-2723
7. Luo F., Liu X., Wang S., and Chen H. Effect of homocysteine on platelet activation induced by collagen. Nutrition 22 (2006) 69-75
8. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 (1986) 1370-1376
9. Hultburg B., Andersson A., and Isaksson A. The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology 123 (1997) 33-40
10. Mansoor M.A., Bergmark C., Haswell S.J., Savage I.F., Evans P.H., Berge R.K., Svardal A.M., and Kristensen O. Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease. Clin. Chem. 46 (2000) 385-391
11. Dudman N.P.B., and Wilcken D.E.L. Increased plasma copper in patients with homocystinuria due to cystathionine β-synthase deficiency. Clin. Chim. Acta 127 (1983) 105-113
12. He K., Merchant A., Rimm E.B., Rosner B.A., Stampfer M.J., Willett W.C., and Ascherio A. Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35 (2004) 169-174
13. Verhoef P., Meleady R., Daly L.E., Graham I.M., Robinson K., Boers G.H.J., and the European COMAC Group. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. Eur. Heart J. 20 (1999) 1234-1244
14. Schwammenthal Y., and Tanne D. Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials. Lancet Neurol. 3 (2004) 493-495
15. Robinson K., Mayer E.L., Miller D.P., Green R., Lente F., Gupta A., Kottke-Marchant K., Savon S.R., Selhub J., Nissen S.E., Kutner M., Topol E.J., and Jacobsen D.W. Hyperhomocysteinemia and low pyridoxal phosphate: common and independent reversible risk factors for coronary artery disease. Circulation 92 (1995) 2825-2830
16. Friso S., Girelli D., Martinelli N., Olivieri O., Lotto V., Bozzini C., Pizzolo F., Faccini G., Beltrame F., and Corrocher R. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am. J. Clin. Nutr. 79 (2004) 992-998
17. Chen H., and Xiong L. Pyridoxine is required for post-embryonic root development and tolerance to osmotic and oxidative stresses. Plant J. 44 (2005) 396-408
18. Chumnantana R., Yokoichi N., and Yagi T. Vitamin B6 compounds prevent the death of yeast cells due to menadione, a reactive oxygen generator. Biochim. Biophys. Acta 1772 (2005) 84-91
19. Endo N., Nishiyama K., Otsuka A., Kanouchi H., Taga M., and Oka T. Anti-oxidant activity of vitamin B6 delays homocysteine-induced atherosclerosis in rats. Br. J. Nutr. 95 (2006) 1088-1093
20. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C., and Scott J.M. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem. 50 (2004) 3-32
21. Ehrenshaft M., Bilsky P., Li M.Y., Chignell C.F., and Daub M.E. A highly conserved sequence is a novel gene involved in de novo vitamin B6 biosynthesis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9374-9378
22. Nakano E., Williamson M.P., Williams N.H., and Powers H.J. Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation. Biochim. Biophys. Acta 1688 (2004) 33-42
23. Coyle C.H., Martinez L.J., Coleman M.C., Spitz D.R., Weintraub N.L., and Kader K.N. Mechanisms of H2O2-induced oxidative stress in endothelial cells. Free Radic. Biol. Med. 40 (2006) 2206-2213
24. Kachur A.V., Held K.D., Koch C.J., and Biaglow J.E. Mechanism of production of hydroxyl radicals in the copper-catalyzed oxidation of dithiothreitol. Radiat. Res. 147 (1997) 409-415
25. Hermes-Lima M., Goncalves M.S., and Andrade R.G. Pyridoxal isonicotinoyl hydrazone (PIH) prevents copper-mediated in vitro free radical formation. Mol. Cell. Biochem. 228 (2001) 73-82